Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-031804

Chief Legal Officer sold 10,000 shares at $20.00 ($200,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ali-Jackson Kamil Chief Legal Officer 2018-05-18 Sale −10,000 $20.00 $200,000 82,636 D
Open-market sales · 10,000 sh · avg $20.00 · $200,000
Loading xslF345X03/doc4.xml…